Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Any TD Ameritrade account holders out there still seeing glitches with their purchase prices on the positions page?
Thank you BL. Realistic short term expectations are cathartic.
I’ll break the tie. You’re right. It’s not a double negative.
Flip, certainly appreciated by many of us.
Over 57% of the volume was shorted the day it jumped 40% after the journal publication. I find it hard to believe this was accomplished by a bunch of turtles.
Good one!
That’s like Judas telling Jesus he doesn’t trust Him with the money.
We added a tenth to our current share count.
275,000 Yes vote here based on the gun and foot logic.
Aren’t NASA’s shuttles up for auction?
It is grammatically correct for English speakers to use the simple present, or present continuous, verb tense to talk about the future in some contexts. For example, my brother arrives, or is arriving, tonight by train. Or, I am excited about picking my brother up at the train station tonight. I don’t think Chris meant to say he has read the manuscript.
Speaking of lawyers,
Right. As in “HappyLibrarian will allow someone else to have the last word, any day.” :)
Finally, an ask higher at opening than the previous day’s close. I love chasing these pennies.
I need to read more on exercising warrants. Best.
They would be really altruistic if they thought share prices would slide back down and still exercised the warrants.
ou, can your humor be any drier?
Nice opening.
Weren’t their projections based on assumptions?
I think you misundersood. Your .225 was not 2 cents above the ask.
Comforting worried investors is probably not a priority for management right now. If I were in their shoes, having fought all those fights since $12 per share, I wouldn’t say a darn thing either. It won’t have any bearing on the success or failure of DCVax-L, so why waste their breath, only to provide fodder for the likes of AF and others.
I lost $10K in Sept. 2011 when the Swiss pegged their franc to the euro. I closed my forex account the next day with my tail between my legs.
Thank you very much for that.
630,594 (below avg. volume) at 11:00 a.m. EST. I need a tick chart lesson.
Well, I’m not looking at Thinkorswim, but it’s there I presume. No, I see the volume on the basic TDAmeritrade webite’s NWBO Stock Profile Page after I tap “NWBO” on the Positions Page.
My TDAmeritrade is showing 419,120 (Heavy Day)
Many informative and encouraging posts lately.
This tactic has Cofer Black written all over it ;)
Some may be willing to sacrifice style as long as the content is accurate. I almost fell asleep reading it, but it was helpful. :)
Actually, twenty cents to one dollar would be a 400% increase (.8 / .2 = 4) ;)
I’ll give you 16c on Monday if you give me $25 in 2021.
Tough decision. Of course, this short term spike would still be considered a dip three years from now if all goes well for NWBO. But I understand that the trading game is played differently.
I agree. I read the section of the text several times, and I don’t see any evidence of Class I exempt status in the U.S. I interpret the 10-k to state that the AC5 Topical Gel is Class II in the EU and US and that the other AC5 products’ classification has not been determined yet in either location. I’m referring to the following paragraph from the 10-k:
“Medical devices in the EU and the U.S. are classified along a spectrum. Class III status, which is the higher-level classification for devices compared to Classes II and I, involves additional procedures and regulatory scrutiny of the product candidate to obtain approvals. AC5 could be regulated as either a Class III or a Class II medical device in these jurisdictions, depending upon the application, subject to the process for obtaining a CE mark in the EU and the premarketing authorization process in the U.S. It has been determined that our AC5™ Topical Gel used for external wounds will be a Class II medical device.”
So, if the AC5 Topical Gel is approved and begins commercialization before Q4 2018, when the cash on hand will be depleted requiring financing/dilution, then ARCH will be in great shape going forward. This is just my opinion.
The MM do their thing, and I do mine, which is to buy and average down during the dips. I’m new to ARCH and initially bought in the .70s.
FYI, I have a margin approved account with TDAmeritrade, and so Level 2 bid/ask data is free with their Think or Swim app.
On ARTH Level 2 bid and ask, I see CSTI, NITE, and CDEL, market makers that have manipulated NWBO’s share price to death this past year. This is not a good sign in the short term, but good news will win the day eventually IMO.
I think it will be just the same as before, OS data needs to mature to increase the likelihood of L being approved so that patients get access and your investment doesn’t get wiped out.
That’s an often lost but important fact which supports a long strategy.
That’s my guess, too. I remember reading on this board about the recent activities in Canada, but I won’t be disappointed if I’m wrong.